Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

The DQB1*03 allele is linked to higher alopecia areata risk in Italians.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

Low BMI and cold exposure increase the risk of chilblains.

Connexin-26 gene mutations may increase cancer risk in KID syndrome patients.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

CLEC4D gene variants may increase the risk of alopecia areata in Jordanians.

Women with prediabetes may have a higher risk of PCOS-like changes, especially if they have impaired glucose tolerance.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Finasteride does not increase the risk of suicide attempts.

Wnt-activating drugs generally do not increase cancer risk.

COVID-19 vaccines do not increase the risk of alopecia areata.

Alopecia areata patients have a higher risk of blood clots.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Loss of TET2 increases the risk of skin and oral cancer.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

Psoriasis is linked to a higher risk of autoimmune diseases and other health conditions.

Male pattern baldness may be linked to prostate cancer risk.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

SHBG may be a useful early indicator and treatment target for PCOS.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

Tree leaves and lichens can effectively indicate air pollution levels in cities.